119 related articles for article (PubMed ID: 11874627)
1. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis.
Kruyt FA; Curiel DT
Hum Gene Ther; 2002 Mar; 13(4):485-95. PubMed ID: 11874627
[TBL] [Abstract][Full Text] [Related]
2. Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy.
Oosterhoff D; van Beusechem VW
J Exp Ther Oncol; 2004 Apr; 4(1):37-57. PubMed ID: 15255291
[TBL] [Abstract][Full Text] [Related]
3. Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.
Abou El Hassan MA; van der Meulen-Muileman I; Abbas S; Kruyt FA
J Virol; 2004 Nov; 78(22):12243-51. PubMed ID: 15507611
[TBL] [Abstract][Full Text] [Related]
4. Engineering regulatory elements for conditionally-replicative adeno-viruses.
Haviv YS; Curiel DT
Curr Gene Ther; 2003 Aug; 3(4):357-85. PubMed ID: 12871022
[TBL] [Abstract][Full Text] [Related]
5. Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy.
Li S; Ou M; Wang G; Tang L
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8325-35. PubMed ID: 27557721
[TBL] [Abstract][Full Text] [Related]
6. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
Nettelbeck DM
Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
[TBL] [Abstract][Full Text] [Related]
7. Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
Lam JT; Kanerva A; Bauerschmitz GJ; Takayama K; Suzuki K; Yamamoto M; Bhoola SM; Liu B; Wang M; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
J Gene Med; 2004 Dec; 6(12):1333-42. PubMed ID: 15493039
[TBL] [Abstract][Full Text] [Related]
8. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
[TBL] [Abstract][Full Text] [Related]
9. Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.
Jiang G; Xin Y; Zheng JN; Liu YQ
Int J Cancer; 2011 Jul; 129(2):263-74. PubMed ID: 21509783
[TBL] [Abstract][Full Text] [Related]
10. Replicating adenoviruses in cancer therapy.
Dobbelstein M
Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
[TBL] [Abstract][Full Text] [Related]
11. Replication-selective oncolytic viruses in the treatment of cancer.
Everts B; van der Poel HG
Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus.
Rein DT; Volkmer A; Beyer IM; Curiel DT; Janni W; Dragoi A; Hess AP; Maass N; Baldus SE; Bauerschmitz G; Breidenbach M
Gynecol Oncol; 2011 Oct; 123(1):138-46. PubMed ID: 21741695
[TBL] [Abstract][Full Text] [Related]
13. Armed replicating adenoviruses for cancer virotherapy.
Cody JJ; Douglas JT
Cancer Gene Ther; 2009 Jun; 16(6):473-88. PubMed ID: 19197323
[TBL] [Abstract][Full Text] [Related]
14. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
[TBL] [Abstract][Full Text] [Related]
15. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
[TBL] [Abstract][Full Text] [Related]
16. A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma.
Kanerva A; Bauerschmitz GJ; Yamamoto M; Lam JT; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
Gene Ther; 2004 Mar; 11(6):552-9. PubMed ID: 14999227
[TBL] [Abstract][Full Text] [Related]
17. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
18. Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment.
Davydova J; Le LP; Gavrikova T; Wang M; Krasnykh V; Yamamoto M
Cancer Res; 2004 Jun; 64(12):4319-27. PubMed ID: 15205347
[TBL] [Abstract][Full Text] [Related]
19. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
[TBL] [Abstract][Full Text] [Related]
20. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
Zhu ZB; Mathis JM; Makhija SK; Lu B; Wang M; Ji S; Rivera AA; Rosenthal EL; Siegal GP; Curiel DT
Int J Oncol; 2007 Nov; 31(5):1213-22. PubMed ID: 17912450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
